- Home
- NMIH vs VCYT Comparison
NMIH vs VCYT Comparison
Compare NMIH & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMIH
- VCYT
- Stock Information
- Founded
- NMIH 2011
- VCYT 2006
- Country
- NMIH United States
- VCYT United States
- Employees
- NMIH N/A
- VCYT 824
- Industry
- NMIH Property-Casualty Insurers
- VCYT Medical Specialities
- Sector
- NMIH Finance
- VCYT Health Care
- Exchange
- NMIH Nasdaq
- VCYT Nasdaq
- Market Cap
- NMIH 2.9B
- VCYT 2.8B
- IPO Year
- NMIH 2013
- VCYT 2013
- Fundamental
- Price
- NMIH $35.84
- VCYT $35.81
- Analyst Decision
- NMIH Buy
- VCYT Strong Buy
- Analyst Count
- NMIH 6
- VCYT 9
- Target Price
- NMIH $42.33
- VCYT $40.44
- AVG Volume (30 Days)
- NMIH 369.6K
- VCYT 812.6K
- Earning Date
- NMIH 11-04-2025
- VCYT 11-04-2025
- Dividend Yield
- NMIH N/A
- VCYT N/A
- EPS Growth
- NMIH 11.30
- VCYT N/A
- EPS
- NMIH 4.71
- VCYT 0.34
- Revenue
- NMIH $679,621,000.00
- VCYT $479,129,000.00
- Revenue This Year
- NMIH N/A
- VCYT $14.48
- Revenue Next Year
- NMIH $5.15
- VCYT $9.79
- P/E Ratio
- NMIH $7.60
- VCYT $106.72
- Revenue Growth
- NMIH 9.99
- VCYT 19.91
- 52 Week Low
- NMIH $31.90
- VCYT $22.61
- 52 Week High
- NMIH $43.20
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- NMIH 35.08
- VCYT 62.31
- Support Level
- NMIH $35.11
- VCYT $33.20
- Resistance Level
- NMIH $36.52
- VCYT $35.33
- Average True Range (ATR)
- NMIH 0.66
- VCYT 1.35
- MACD
- NMIH -0.10
- VCYT -0.13
- Stochastic Oscillator
- NMIH 17.21
- VCYT 71.10
About NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.